Lucid Diagnostics Inc. ( LUCD) - Key Metrics
LUCD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.06 | -$0.06 | -$0.06 |
| 2026Q1 | $0.01 | -$0.14 | -$0.12 | -$0.12 |
| 2025Q4 | $0.01 | -$0.16 | -$0.12 | -$0.12 |
| 2025Q3 | $0.01 | -$0.10 | -$0.10 | -$0.10 |
| 2025Q2 | $0.01 | -$0.04 | -$0.11 | -$0.11 |
LUCD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.34 |
| 2026Q1 | 0% | -1.69 |
| 2025Q4 | 0% | -2.27 |
| 2025Q3 | 0% | -2.63 |
| 2025Q2 | 0% | -3.61 |
LUCD
Price: $1
52 week price:
Earnings Per Share: -0.42 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 72027
Market Capitalization: 186.7 million